Molly A. Taylor

2.2k total citations
30 papers, 1.7k citations indexed

About

Molly A. Taylor is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Molly A. Taylor has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Molly A. Taylor's work include MicroRNA in disease regulation (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (5 papers). Molly A. Taylor is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (5 papers). Molly A. Taylor collaborates with scholars based in United States, United Kingdom and Singapore. Molly A. Taylor's co-authors include William P. Schiemann, Jenny G. Parvani, Khalid Sossey‐Alaoui, Michael K. Wendt, Barbara J. Schiemann, Cheryl L. Thompson, David Danielpour, Rebecca L. O’Brien, Willi K. Born and Christina L. Roark and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Cancer Research.

In The Last Decade

Molly A. Taylor

30 papers receiving 1.6k citations

Peers

Molly A. Taylor

ONCOL

IMMUN

PRM

Tsz-Lun Yeung United States

Cameron N. Johnstone Australia

Cecilia S. Leung United States

Tina El Rayes United States

Pinaki Bose Canada

Jessica Pahler United States

Ernst J.A. Steller Netherlands

Hiroki Hashida Japan

Alessandra Rustighi Italy

Roderik M. Kortlever United States

Tsz-Lun Yeung United States

Molly A. Taylor

1.3k ×1.3

514 ×0.8

ONCOL

875 ×1.7

291 ×0.7

IMMUN

164 ×1.1

PRM

Citations per year, relative to Molly A. Taylor Molly A. Taylor (= 1×) peers Tsz-Lun Yeung

Countries citing papers authored by Molly A. Taylor

Since Specialization

Citations

This map shows the geographic impact of Molly A. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly A. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly A. Taylor more than expected).

Fields of papers citing papers by Molly A. Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly A. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly A. Taylor. The network helps show where Molly A. Taylor may publish in the future.

Co-authorship network of co-authors of Molly A. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Molly A. Taylor. A scholar is included among the top collaborators of Molly A. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly A. Taylor. Molly A. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor, Molly A., Kevin Litwiler, Qian Zhao, et al.. (2024). Abstract LB174: OKI-219 is an inhibitor of PI3Kα H1047R that has brain penetrance and anti-tumor activity in a preclinical intracranial model of metastatic breast cancer. Cancer Research. 84(7_Supplement). LB174–LB174. 1 indexed citations

Carnevalli, Larissa S., Molly A. Taylor, Matthew King, et al.. (2021). Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition. Molecular Cancer Therapeutics. 20(6). 1080–1091. 14 indexed citations

Taylor, Molly A., Adina Hughes, Josephine Walton, et al.. (2019). Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery. Journal for ImmunoTherapy of Cancer. 7(1). 328–328. 70 indexed citations

Langdon, Sophie, Adina Hughes, Molly A. Taylor, et al.. (2018). Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity. OncoImmunology. 7(8). e1458810–e1458810. 40 indexed citations

Bizzaro, Francesca, Alessandra Decio, Francesca Ricci, et al.. (2018). Abstract 2816: Patient derived ovarian cancer xenograft (OC-PDX) to study the response of the PARP inhibitor olaparib. Cancer Research. 78(13_Supplement). 2816–2816. 1 indexed citations

Carnevalli, Larissa S., Charles Sinclair, Molly A. Taylor, et al.. (2018). PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity. Journal for ImmunoTherapy of Cancer. 6(1). 158–158. 71 indexed citations

Taylor, Molly A., Mark Wappett, Oona Delpuech, Helen Brown, & Christine M. Chresta. (2016). Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC. Oncogene. 35(33). 4345–4357. 28 indexed citations

Hijaz, Miriana, Jasdeep Chhina, İsmail Mert, et al.. (2016). Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer. Gynecologic Oncology. 142(2). 323–331. 25 indexed citations

Bell, Emma & Molly A. Taylor. (2016). Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment. Computational and Structural Biotechnology Journal. 15. 8–13. 70 indexed citations

10.

Taylor, Molly A.. (2015). Targeting microRNAs in cancer. The biomedical & life sciences collection.. 2015(12). e1004066–e1004066. 2 indexed citations

11.

Taylor, Molly A.. (2015). Circulating MicroRNAs as Biomarkers and Mediators of Cell–Cell Communication in Cancer. Biomedicines. 3(4). 270–281. 9 indexed citations

12.

Taylor, Molly A., Gangarao Davuluri, Jenny G. Parvani, et al.. (2013). Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Research and Treatment. 142(2). 341–353. 52 indexed citations

13.

Taylor, Molly A., Khalid Sossey‐Alaoui, Cheryl L. Thompson, David Danielpour, & William P. Schiemann. (2012). TGF-β upregulates miR-181a expression to promote breast cancer metastasis. Journal of Clinical Investigation. 123(1). 150–163. 251 indexed citations

14.

Taylor, Molly A., et al.. (2011). Lysyl Oxidase Contributes to Mechanotransduction-Mediated Regulation of Transforming Growth Factor-β Signaling in Breast Cancer Cells. Neoplasia. 13(5). 406–IN2. 82 indexed citations

15.

Parvani, Jenny G., Molly A. Taylor, & William P. Schiemann. (2011). Noncanonical TGF-β Signaling During Mammary Tumorigenesis. Journal of Mammary Gland Biology and Neoplasia. 16(2). 127–146. 99 indexed citations

16.

Wendt, Michael K., Molly A. Taylor, Barbara J. Schiemann, & William P. Schiemann. (2011). Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Molecular Biology of the Cell. 22(14). 2423–2435. 144 indexed citations

17.

Taylor, Molly A., et al.. (2010). Intracellular localization and interaction of mRNA binding proteins as detected by FRET. BMC Cell Biology. 11(1). 69–69. 17 indexed citations

18.

Taylor, Molly A., Jenny G. Parvani, & William P. Schiemann. (2010). The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β in Normal and Malignant Mammary Epithelial Cells. Journal of Mammary Gland Biology and Neoplasia. 15(2). 169–190. 195 indexed citations

19.

Roark, Christina L., Jena D. French, Molly A. Taylor, et al.. (2007). Exacerbation of Collagen-Induced Arthritis by Oligoclonal, IL-17-Producing γδ T Cells. The Journal of Immunology. 179(8). 5576–5583. 254 indexed citations

20.

Sokol, Ronald J., S. Hewitt, D.J. Booker, et al.. (1985). Fatal immune haemolysis associated with nomifensine.. BMJ. 291(6491). 311.2–312. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact